S4332Referred to Committee
A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.
Introduced
2
In Committee3
Passed One Chamber4
Passed Both5
Signed into Law119th
Congress
2026-04-16
Introduced
1
Cosponsors
S
ⓘType
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2026-04-16
Read the full bill text
